Avantor (AVTR) Change in Accured Expenses (2019 - 2026)
Avantor (AVTR) recorded quarterly Change in Accured Expenses of -$15.7 million in Q1 2026, down 229.75% quarter-over-quarter from $12.1 million in Q4 2025, and down 68.82% on a YoY basis from -$50.3 million in Q1 2025.
Avantor (AVTR) Change in Accured Expenses (2019 - 2026) Analysis & Trends
Avantor's Change in Accured Expenses history runs 8 years deep, the most recent figure standing at -$15.7 million for Q1 2026.
- In Q1 2026, Change in Accured Expenses fell 68.82% year-over-year to -$15.7 million; the TTM figure through Mar 2026 stood at -$7.7 million (down 450.0% YoY), while the FY2025 annual figure was -$1.3 million, up 18.75% from the prior year.
- Change in Accured Expenses was -$15.7 million for Q1 2026 at Avantor, down from $12.1 million in the prior quarter.
- In the past five years, Change in Accured Expenses ranged from a high of $14.9 million in Q4 2024 to a low of -$16.2 million in Q3 2024.
- Historically, Change in Accured Expenses has averaged -$1.1 million across 5 years, with a median of -$9.3 million in 2025.
- The sharpest annual moves came in 2022 and 2026: Change in Accured Expenses soared 43.5% in 2022, then slumped 68.82% in 2026.
- A 5-year view of Change in Accured Expenses shows it stood at $11.3 million in 2022, then decreased by 6.19% to $10.6 million in 2023, then soared by 40.57% to $14.9 million in 2024, then slipped by 18.79% to $12.1 million in 2025, then slumped by 229.75% to -$15.7 million in 2026.
- The last three Change in Accured Expenses figures came in at -$15.7 million (Q1 2026), $12.1 million (Q4 2025), and -$14.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Accured Exp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | -284.70 Mn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | - |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | -32.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 103.88 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | - |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | -151.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | - |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 5.38 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 203.00 Mn |
| 10 | Avantor | 6.47 Bn | 6.19 Bn | 500.70 Mn | -15.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -15.70 Mn |
| Mar 31, 2026 | -15.70 Mn |
| Dec 31, 2025 | 12.10 Mn |
| Dec 31, 2025 | 12.10 Mn |
| Sep 30, 2025 | -14.80 Mn |
| Sep 30, 2025 | -14.80 Mn |
| Jun 30, 2025 | 10.70 Mn |
| Jun 30, 2025 | 10.70 Mn |
| Mar 31, 2025 | -9.30 Mn |
| Mar 31, 2025 | -9.30 Mn |
| Dec 31, 2024 | 14.90 Mn |
| Dec 31, 2024 | 14.90 Mn |
| Sep 30, 2024 | -16.20 Mn |
| Sep 30, 2024 | -16.20 Mn |
| Jun 30, 2024 | 9.20 Mn |
| Jun 30, 2024 | 9.20 Mn |
| Mar 31, 2024 | -9.50 Mn |
| Mar 31, 2024 | -9.50 Mn |
| Dec 31, 2023 | 10.60 Mn |
| Dec 31, 2023 | 10.60 Mn |